Moneycontrol
Get App
Last Updated : Oct 14, 2019 03:49 PM IST | Source: Moneycontrol.com

Cadila Healthcare Q2 PAT may dip 23% YoY to Rs. 321.5 cr: Emkay

Net Sales are expected to increase by 17.4 percent Y-o-Y (down 0.6 percent Q-o-Q) to Rs. 3,475.2 crore, according to Emkay.

Representative Image.
Representative Image.
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Emkay has come out with its second quarter (July-September’ 19) earnings estimates for the Pharmaceuticals sector. The brokerage house expects Cadila Healthcare to report net profit at Rs. 321.5 crore down 23% year-on-year (up 6% quarter-on-quarter).


Net Sales are expected to increase by 17.4 percent Y-o-Y (down 0.6 percent Q-o-Q) to Rs. 3,475.2 crore, according to Emkay.


Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to fall by 5 percent Y-o-Y (up 4 percent Q-o-Q) to Rs. 655.6 crore.


Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.




Exclusive offer: Use code "BUDGET2020" and get Moneycontrol Pro's Subscription for as little as Rs 333/- for the first year.

First Published on Oct 14, 2019 03:49 pm
Sections
Follow us on